Psomagen, Inc. (KOSDAQ:950200)
3,640.00
-135.00 (-3.58%)
At close: Apr 28, 2026
Psomagen Market Cap
Psomagen has a market cap or net worth of 70.02 billion as of April 28, 2026. Its market cap has increased by 4.45% in one year.
Market Cap
70.02B
Enterprise Value
69.56B
Revenue
59.19B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,640.00
Market Cap Chart
Since July 13, 2020, Psomagen's market cap has decreased from 254.61B to 70.02B, a decrease of -72.50%. That is a compound annual growth rate of -19.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 72.62B | -2.71% |
| Dec 30, 2025 | 74.64B | -4.20% |
| Dec 30, 2024 | 77.91B | -20.59% |
| Dec 28, 2023 | 98.10B | -34.17% |
| Dec 29, 2022 | 149.03B | -12.38% |
| Dec 30, 2021 | 170.10B | -50.35% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CTCBIO | 92.77B |
| Quratis | 89.51B |
| Shaperon | 86.57B |
| Naturalendo Tech | 86.20B |
| PanGen Biotech | 81.10B |
| IMGT Co.,Ltd. | 78.79B |
| Progen | 76.49B |
| Ark Solutions | 68.91B |